Personal Finance
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
The IRS raised the health Flexible Spending Account cap to $3,500 starting in 2027, giving employees a chance to lower taxable income…
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
Fidelity’s new retirement investing strategy impacts fees and access for average 401(k) savers, requiring careful review of statements.
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
Break down the concept of RMDs, their rules, current age thresholds, and practical tips like Roth conversions for managing tax implications.
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
The IRS raises the elective deferral limit by $1,000 and expands catch-up contributions for workers 50 and older, creating new tax-deferral opportunities.
-
IRS Raises Annual Gift Exclusion to $20,000 for 2027, Enabling $320,000 Tax-Free Transfer for Couples
Inflation adjustment allows married couples to gift $40,000 per recipient annually without filing returns, accelerating estate reduction for high-net-worth families.
-
Medicare Part D Cap Rise to $2,400 Outweighs 2027 Ozempic Price Cuts
Patients relying on maintenance drugs like Ozempic face higher annual spending caps in 2027 despite new Medicare price negotiations.
-
Financial and Systemic Barriers Impede Early Bladder Cancer Care for Younger Veterans
A new national survey reveals that 63% of military service members and veterans with non-muscle invasive bladder cancer face severe systemic care…
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
A new survey reveals that 71% of U.S. consumers feel their finances are stagnating, highlighting the growing reliance on debt to cover…
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
As the Federal Reserve shifts course on interest rates, high-yield certificates of deposit offer savers guaranteed returns up to 5.05% APY.
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
Despite FDA advisory support, CMS excludes Galleri from coverage, forcing patients to pay out-of-pocket while awaiting a 2029 policy shift.
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
Following recent neuro-pharmaceutical acquisitions and drug approvals, we assess AbbVie’s pipeline strategy, financial impact, and key shareholder risks.
-
How Ueno Bank’s Collapse Toppled Paraguay’s President and Shook Financial Trust
A digital lender serving 60% of adults failed amid insider-lending allegations, triggering a deposit freeze, mass protests, and the impeachment of President…
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Star Health’s ₹780 Crore Cancer Payouts Signal Rising Claims Burden for Policyholders
Insurer settles 85,900 cancer claims in H1 FY27, with women and the 51-60 age group driving a 17% surge in payouts.
-
How Missing Bank Statements Trigger Medicaid Denials and $41,000 Bills for Nursing Home Residents
A nursing home files a Medicaid application as a courtesy but omits three bank statements, leaving the family liable for four months…
-
Claude’s New Personal Finance Tool Lets Users Spot Spending Leaks via Chat
Anthropic’s new feature connects to bank accounts via Plaid, allowing users to ask conversational questions to categorize spending and flag duplicate charges.
-
Why ACA Premiums Are Rising Again in 2027
Double-digit premium hikes return as federal subsidies expire and healthcare costs climb, leaving middle-income families facing higher bills and fewer options.
-
Bank of England Raises Interest Rate
The Bank of England raises interest rates to 4% to control rising inflation driven by global energy prices
-
How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees
A retiree’s capital gains from selling investments can trigger higher Medicare Part B premiums two years later, a surprise cost many overlook.
-
Inovio’s First FDA Approval Tests Whether DNA Medicines Can Pay Off for Retail Investors
Voceryq’s accelerated approval for a rare throat disease gives the Plymouth Meeting biotech its first product revenue, but confirmatory trials and a…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























